Ibrance 100 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F5VFE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,560
Award facts
- Contract value 100% obligated
- $8,559.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count packaging) with a firm fixed-price structure. This non-set-aside award was issued on January 12, 2026, with an ultimate completion date of February 3, 2026. The contractor will perform this work from its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999.99 billion through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical procurement system, particularly supporting the Defense Health Agency and military treatment facilities. The company's contract awards demonstrate extensive capability in fulfilling federal medical supply requirements across diverse therapeutic domains, including oncology treatments such as Ibrance. As a major pharmaceutical distributor operating through competitive acquisition processes, the contractor maintains a robust portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical commodities essential to military and veteran healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F5VFE?
SPE2DR26F5VFE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F5VFE worth?
The government has obligated $8,560 on SPE2DR26F5VFE.
Is contract SPE2DR26F5VFE an order under another contract?
Yes. SPE2DR26F5VFE is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5VFE competed?
The extent of competition for SPE2DR26F5VFE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award